Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)

China flag China · Delayed Price · Currency is CNY
41.83
-4.08 (-8.89%)
At close: Aug 3, 2026
Market Cap3.88B +20.2%
Revenue (ttm)233.67M -35.1%
Net Income24.32M -64.1%
EPS0.26 -63.9%
Shares Out 92.77M
PE Ratio160.06
Forward PEn/a
Dividend0.21 (0.47%)
Ex-Dividend DateJun 12, 2026
Volume11,796,019
Open45.02
Previous Close45.91
Day's Range41.00 - 46.20
52-Week Range23.18 - 71.80
Beta0.49
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHE:301520

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. provides pharmaceutical research and clinical research services in China. The company offers service platform for pharmaceutical research, raw materials, clinical research, medical device services, biological sample analysis, SMO service, and statistical analysis. It also provides precision nutrition cooperation and ecosystem platform; and drug platform. The company was incorporated in 2006 and is based in Hefei, China. [Read more]

Industry Commercial Physical and Biological Research
Founded 2006
Employees 370
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301520
Full Company Profile

Financial Performance

In 2025, SHE:301520's revenue was 274.18 million, a decrease of -27.67% compared to the previous year's 379.09 million. Earnings were 36.43 million, a decrease of -57.40%.

Financial Statements